Berkshire Capital Holdings’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10
Closed 89
2022
Q3
$0 Hold
10
﹤0.01% 84
2022
Q2
$1K Hold
10
﹤0.01% 76
2022
Q1
$1K Hold
10
﹤0.01% 68
2021
Q4
$1K Hold
10
﹤0.01% 72
2021
Q3
$1K Hold
10
﹤0.01% 76
2021
Q2
$2K Hold
10
﹤0.01% 65
2021
Q1
$2K Hold
10
﹤0.01% 60
2020
Q4
$2K Hold
10
﹤0.01% 56
2020
Q3
$2K Buy
+10
New +$2.12K ﹤0.01% 50

Other funds holding TDOC

Berkshire Capital Holdings's TDOC Position: Q4 2022 in Review

Berkshire Capital Holdings sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 10 shares.

Berkshire Capital Holdings first reported a position in TDOC in Q3 2020 and held it in 9 quarters. The position peaked at $2K in Q2 2021. 444 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Berkshire Capital Holdings reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Berkshire Capital Holdings sold 10 Teladoc Health shares in Q4 2022.
  • Berkshire Capital Holdings first reported a position in Teladoc Health in Q3 2020 and held it in 9 quarters.
  • Berkshire Capital Holdings's Teladoc Health position peaked at $2K in Q2 2021.
  • 444 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Berkshire Capital Holdings's 13F filing for Q4 2022, filed 13 Feb 2023.